FDA Warns Pfizer About Pediatric Trials of Geodon
On April 9th, the FDA issued a Warning Letter to Pfizer, Inc. concerning its conduct during a clinical trial for one of its prescription drugs…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: Clinical Trials
FDA’s Postmarketing Studies and Clinical Trials Draft Guidance Gets Supported By Public Citizen
In an October 13 letter to the FDA, the well respected consumer advocacy organization Public Citizen, gave a strong endorsement to the FDA Draft Guidance…
Read More »CRO’s Conflict of Interest
St. Petersburg Reporter Chris Hundley wrote (July 1, 2007) a well-written, balanced and comprehensive (as can get in an article) about Contract Research Organizations (CRO’s). …
Read More »Pharma Has Its Nose In Clinical Trials
A survey published in the New York Journal of Medicine found that more than a third of experts who oversee clinical trials at both medical…
Read More »Guess What Else is NOT a Top Priority of the FDA?
Answer: Monitoring postmarketing study commitments. The FDA lacks an effective system for monitoring postmarketing study commitments. See the latest OIG Report, dated June 2006.
Read More »